Kizeev G, Witteveen I, Balmer T
Cerebellum. 2024; 24(1):16.
PMID: 39699796
DOI: 10.1007/s12311-024-01767-x.
Kizeev G, Witteveen I, Balmer T
bioRxiv. 2024; .
PMID: 39416048
PMC: 11482929.
DOI: 10.1101/2024.10.10.617602.
Zhu J, Qiu W, Wei F, Zhang J, Yuan Y, Liu L
Cell Death Dis. 2024; 15(8):594.
PMID: 39147737
PMC: 11327311.
DOI: 10.1038/s41419-024-06988-w.
Bollu T, Whitehead S, Prasad N, Walker J, Shyamkumar N, Subramaniam R
J Neurophysiol. 2024; 132(3):829-848.
PMID: 39081209
PMC: 11427071.
DOI: 10.1152/jn.00241.2023.
Kroneberg D, Numann A, Minnerop M, Ronnefarth M, Endres M, Kuhn A
Sensors (Basel). 2024; 24(11).
PMID: 38894268
PMC: 11174553.
DOI: 10.3390/s24113476.
Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.
Qiu Q, Yang M, Gong D, Liang H, Chen T
Neural Regen Res. 2024; 20(5):1258-1276.
PMID: 38845230
PMC: 11624876.
DOI: 10.4103/NRR.NRR-D-23-01766.
A combination of chlorzoxazone and folic acid improves recognition memory, anxiety and depression in SCA3-84Q mice.
Marinina K, Bezprozvanny I, Egorova P
Hum Mol Genet. 2024; 33(16):1406-1419.
PMID: 38727562
PMC: 11305683.
DOI: 10.1093/hmg/ddae079.
SEL1L-HRD1 interaction is required to form a functional HRD1 ERAD complex.
Lin L, Wang H, Pederson B, Wei X, Torres M, Lu Y
Nat Commun. 2024; 15(1):1440.
PMID: 38365914
PMC: 10873344.
DOI: 10.1038/s41467-024-45633-0.
Increased intrinsic membrane excitability is associated with hypertrophic olivary degeneration in spinocerebellar ataxia type 1.
Morrison L, Huang H, Handler H, Fu M, Bushart D, Pappas S
bioRxiv. 2023; .
PMID: 37961407
PMC: 10634770.
DOI: 10.1101/2023.10.23.563657.
A chlorzoxazone-folic acid combination improves cognitive affective decline in SCA2-58Q mice.
Marinina K, Bezprozvanny I, Egorova P
Sci Rep. 2023; 13(1):12588.
PMID: 37537226
PMC: 10400576.
DOI: 10.1038/s41598-023-39331-y.
A dual Purkinje cell rate and synchrony code sculpts reach kinematics.
Nashef A, Spindle M, Calame D, Person A
bioRxiv. 2023; .
PMID: 37503038
PMC: 10370034.
DOI: 10.1101/2023.07.12.548720.
An activator of voltage-gated K channels Kv1.1 as a therapeutic candidate for episodic ataxia type 1.
Servettini I, Talani G, Megaro A, Setzu M, Biggio F, Briffa M
Proc Natl Acad Sci U S A. 2023; 120(31):e2207978120.
PMID: 37487086
PMC: 10401004.
DOI: 10.1073/pnas.2207978120.
Basket to Purkinje Cell Inhibitory Ephaptic Coupling Is Abolished in Episodic Ataxia Type 1.
Martin H, Kullmann D
Cells. 2023; 12(10).
PMID: 37408217
PMC: 10216961.
DOI: 10.3390/cells12101382.
Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia.
Huang H, Shakkottai V
Life (Basel). 2023; 13(6).
PMID: 37374132
PMC: 10302946.
DOI: 10.3390/life13061350.
Development and validation of an ultrahigh-performance liquid chromatography-tandem mass spectrometry method to investigate the plasma pharmacokinetics of a K 2.2/K 2.3 positive allosteric modulator in mice.
Rahman M, Chandrashekar D, Nam Y, Syed B, Salehi D, Montazeri Aliabadi H
Rapid Commun Mass Spectrom. 2023; 37(15):e9537.
PMID: 37184249
PMC: 10330529.
DOI: 10.1002/rcm.9537.
Cerebellar granule cell signaling is indispensable for normal motor performance.
Lee J, Khan M, Stark A, Seo S, Norton A, Yao Z
Cell Rep. 2023; 42(5):112429.
PMID: 37141091
PMC: 10258556.
DOI: 10.1016/j.celrep.2023.112429.
Lobule-Related Action Potential Shape- and History-Dependent Current Integration in Purkinje Cells of Adult and Developing Mice.
Beekhof G, Schonewille M
Cells. 2023; 12(4).
PMID: 36831290
PMC: 9953991.
DOI: 10.3390/cells12040623.
What Is the Role of Norepinephrine in Cerebellar Modulation and Stress-Induced Episodic Ataxia?.
Benarroch E
Neurology. 2023; 100(8):383-386.
PMID: 36806456
PMC: 9984211.
DOI: 10.1212/WNL.0000000000206882.
Loss-of-function K2.2 mutations abolish channel activity.
Nam Y, Rahman M, Yang G, Orfali R, Cui M, Zhang M
Am J Physiol Cell Physiol. 2023; 324(3):C658-C664.
PMID: 36717104
PMC: 10069973.
DOI: 10.1152/ajpcell.00584.2022.
Functional Characterization of Four Known Cav2.1 Variants Associated with Neurodevelopmental Disorders.
Folacci M, Estaran S, Menard C, Bertaud A, Rousset M, Roussel J
Membranes (Basel). 2023; 13(1).
PMID: 36676903
PMC: 9864995.
DOI: 10.3390/membranes13010096.